114 related articles for article (PubMed ID: 2716216)
1. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
[TBL] [Abstract][Full Text] [Related]
2. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the mechanism of defective natural killer cytotoxicity in patients with multiple myeloma].
Funato T; Koide A; Ohtani H; Saito M
Gan No Rinsho; 1984 Apr; 30(4):368-72. PubMed ID: 6727037
[TBL] [Abstract][Full Text] [Related]
4. Impaired natural killer cell recycling in childhood chronic neutropenia with morphological abnormalities and defective chemotaxis of neutrophils.
Komiyama A; Kawai H; Yamada S; Aoyama K; Yamazaki M; Saitoh H; Miyagawa Y; Akabane T; Uehara Y
Blood; 1985 Jul; 66(1):99-105. PubMed ID: 3873972
[TBL] [Abstract][Full Text] [Related]
5. [Natural killer cell activity in Naegleria fowleri infected mice].
Lee KR; Shin CO; Im K
Kisaengchunghak Chapchi; 1991 Sep; 29(3):267-77. PubMed ID: 1786253
[TBL] [Abstract][Full Text] [Related]
6. [Natural killer cell activity in mice infected with Acanthamoeba culbertsoni].
Hyun DK; Shin CO; Im K
Kisaengchunghak Chapchi; 1992 Jun; 30(2):101-12. PubMed ID: 1627498
[TBL] [Abstract][Full Text] [Related]
7. Functional properties of natural killer cells in carcinoma of the prostate.
Wirth M; Schmitz-Dräger BJ; Ackermann R
J Urol; 1985 Jun; 133(6):973-8. PubMed ID: 3999223
[TBL] [Abstract][Full Text] [Related]
8. Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome.
Yang FC; Yabuhara A; Koike K
Int J Hematol; 1994 Jun; 59(4):273-80. PubMed ID: 8086621
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity in patients with prostatic carcinoma and its in vivo boosting with bacillus Calmette-Guérin.
Schwemmer B; Lehmer A; Hofmann R; Braun J
Urol Int; 1984; 39(6):321-6. PubMed ID: 6523641
[TBL] [Abstract][Full Text] [Related]
10. Characterization of effector cells responsible for cell-mediated cytotoxicity in patients with carcinoma of the prostate.
Ackermann R; Wirth M; Hasler L; Okabe T
Urol Int; 1981; 36(1):46-52. PubMed ID: 6973229
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell activity of prostatic cancer patients.
Choe BK; Frost P; Morrison MK; Rose NR
Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
13. [Functional abnormalities of natural killer cells in childhood hemophagocytic syndrome].
Yang FC; Yabuhara A; Koike K; Komiyama A
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):36-44. PubMed ID: 7553037
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced NK augmentation in humans. An analysis of target recognition, effector cell recruitment and effector cell recycling.
Ullberg M; Merrill J; Jondal M
Scand J Immunol; 1981 Sep; 14(3):285-92. PubMed ID: 6173918
[TBL] [Abstract][Full Text] [Related]
15. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
16. Recycling and target binding capacity of human natural killer cells.
Ullberg M; Jondal M
J Exp Med; 1981 Mar; 153(3):615-28. PubMed ID: 7252409
[TBL] [Abstract][Full Text] [Related]
17. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
[TBL] [Abstract][Full Text] [Related]
18. Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas.
Gudmundsdóttir I; Ogmundsdóttir HM
APMIS; 1992 Aug; 100(8):737-46. PubMed ID: 1325805
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient.
Vidaller A; Guadarrama F; Llorente L; Méndez JB; Larrea F; Villa AR; Alarcón-Segovia D
J Clin Immunol; 1992 May; 12(3):210-5. PubMed ID: 1400902
[TBL] [Abstract][Full Text] [Related]
20. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
